Nowadays, the use of central venous catheter insertion (CVC), has abundantly increased. It is a common technique in critically ill patients who are admitted to intensive care and emergency departments in order to hemodynamic monitoring and fluid and medication administration. In this report, we express a 28-year-old man who has multiple trauma with decreased level of consciousness during a car accident three months ago and needs intensive care and monitoring by central venous catheter placing.
View Article and Find Full Text PDFIntroduction: To reduce mortality in hospitalized patients with COVID-19 and cardiovascular disease (CVD), it is necessary to understand the relationship between patient's symptoms, risk factors, and comorbidities with their mortality rate. To the best of our knowledge, this paper is the first which take into account the determinants like risk factors, symptoms, and comorbidities leading to mortality in CVD patients who are hospitalized with COVID-19.
Methods: This study was conducted on 660 hospitalized patients with CVD and COVID-19 recruited between January 2020 and January 2021 in Iran.
Background: Aspirin resistance is one of the most important factors for arterial thrombotic events in diabetic patients. This study aimed to evaluate aspirin resistance in diabetic patients.
Methods: In this cross-sectional study, 180 patients who received 80 mg of aspirin daily for at least 10 days were studied, and their urinary 11-DH-TXB2 was measured.
Double-J (DJ) stents are the main tools used in urological practice for prevention and treatment of obstruction. Stenting is also mandatory after complicated ureteroscopy or TUL (Transureteral Lithotripsy). Known complications are upper migration of DJ stents into the kidney and lower migration to the bladder.
View Article and Find Full Text PDFObjective: To evaluate acetyl salicylic acid (ASA) resistance in patients with cardiovascular diseases and evaluate correlation with coronary risk factors.
Methods: One hundred and twenty-four patients with stable coronary artery diseases (CAD) were enrolled in this cross sectional study from the outpatient clinic of the Department of Cardiology, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran, between May 2008 and August 2008. All patients had prior history of cardiovascular disease and were under treatment of 80 mg daily ASA for at least 7 days.